Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

Clinical markers combined with HMGB1 polymorphisms to predict efficacy of conventional DMARDs in rheumatoid arthritis patients

Published:2020-12 Issue: Volume:221 Page:108592
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Xu Ke,Ren Xiaoyu,Ju Bomiao,Aihaiti Yirixiati,Cai Yongsong,Zhang Yingang,He Lan,Wang Jing

Funder

National Youth Foundation of China

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference24 articles.

1. Inflammatory arthritis--an exciting confluence of human and animal research;Laufer;Immunol. Rev.,2010

2. Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate;Prasad;Int. J. Rheum. Dis.,2014

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update;Smolen;Ann. Rheum. Dis.,2020

4. Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology;Ho;Clin. Rheumatol.,2019

5. Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk arthritis register;Scire;Arthritis Care Res.,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis;Current Issues in Molecular Biology;2024-04-19

2. Biomarkers for the diagnosis and treatment of rheumatoid arthritis – a systematic review;Postgraduate Medicine;2022-03-16

3. Current insights and future prospects for the pathogenesis and treatment for rheumatoid arthritis;Clinical Immunology;2021-04